- UHRA Home
- Browsing by Author
Browsing by Author "Kirby, M."
Now showing items 1-13 of 13
-
Cardiovascular risk estimation - What is missing?
Kirby, M. (2011)The review paper by Kevin Billups et al. (1) in this issue of the journal is set against a backdrop of the fact that cardiovascular disease (CVD) has become the world’s major cause of death. It was responsible for one-third ... -
Characteristics, Behaviors, and Attitudes of Men Bypassing the Healthcare System When Obtaining Phosphodiesterase Type 5 Inhibitors
Schnetzler, G.; Banks, I.; Kirby, M.; Zou, K.H.; Symonds, T. (2010)Introduction. Men may choose to bypass the healthcare system to obtain a phosphodiesterase type 5 inhibitor (PDE5i). Aim. Evaluate the characteristics and purchasing patterns of men obtaining a PDE5i without prior healthcare ... -
The counterfeit conundrum
Kirby, M. G.; Kirby, M. (2012-03) -
Diagnosis and medical treatment of lower urinary tract symptoms in adult men : Applying specialist guidelines in clinical practice
Oelke, M.; Burger, M.; Castro-Diaz, D.; Chartier-Kastler, E.; Cidre, M.A.J.; Mcnicholas, T.; Radziszewski, P.; Kirby, M. (2012-09)Objective: To review current treatment guidelines (international and national) on managing male lower urinary tract symptoms (LUTS) and to summarize them for easy application in clinical practice. Methods: A group of ... -
Erectile dysfunction and coronary artery disease prediction : evidence-based guidance and consensus
Jackson, G.; Boon, N.; Eardley, I.; Kirby, M.; Dean, J.; Hackett, G.; Montorsi, P.; Montorsi, F.; Vlachopoulos, C.; Kloner, R.; Sharlip, I.; Miner, M. (2010)A significant proportion of men with erectile dysfunction (ED) exhibit early signs of coronary artery disease (CAD), and this group may develop more severe CAD than men without ED (Level 1, Grade A). • The time interval ... -
Impact on clinical practice of the Joint British Societies' cardiovascular risk assessment tools
Kirby, M.; Machen, I. (2009)Objectives: The aim of this study was to evaluate the Joint British Societies' (JBS 2) Factfile, cardiovascular risk assessment paper charts and electronic risk calculator posted to health professionals in general practice. ... -
It is astonishing with how little reading a doctor can practise medicine
Kirby, M. (2011-10-01) -
Long live the difference? : Why women lose out in heart health
Kirby, M. (2012)Although the last 30 years have witnessed a 35-50% decline in mortality from coronary heart disease (CHD) in men in the western world, there has been no equivalent reduction in CHD mortality in women. This may be due to ... -
Overactive bladder : Is there a link to the metabolic syndrome in men?
Kirby, M.; Wagg, A.; Cardozo, L.; Chapple, C.; Castro-Diaz, D.; de Ridder, D.; Espuna-Pons, M.; Haab, F.; Kelleher, C.; Kolbl, H.; Milsom, I.; van Kerrebroeck, P.; Vierhout, M.; Salvatore, S.; Tubaro, A. (2010)It is becoming increasingly clear that a variety of metabolic, cardiovascular, and endocrine factors contribute to male pelvic health. In particular, a growing body of evidence suggests a relationship between lower urinary ... -
Pelvic organ prolapse and overactive bladder
de Boer, T.A.; Salvatore, S.; Cardozo, L.; Chapple, C.; Kelleher, C.; van Kerrebroeck, P.; Kirby, M.; Koelbl, H.; Espuna-Pons, M.; Milsom, I.; Tubaro, A.; Wagg, A.; Vierhout, M. (2010)In this review we try to shed light on the following questions: How frequently are symptoms of overactive bladder (OAB) and is detrusor overactivity (DO) present in patients with pelvic organ prolapse (POP) and is there a ... -
Professional competence of pharmacists in recommending Flomax relief MR (tamsulosin) to men with lower urinary tract symptoms
Kirby, M.; Phillips, G.; Carr, A. (2011)This paper aimed to determine the role of a pharmacy tool, the symptoms-check questionnaire, in supporting pharmacists' recommendations for treatment with Flomax Relief MR (tamsulosin) and to assess its acceptability to ... -
A review of adherence to drug therapy in patients with overactive bladder
Basra, R.K.; Wagg, A.; Chapple, C.; Cardozo, L.; Castro-Diaz, D.; Pons, M.E.; Kirby, M.; Milsom, I.; Vierhout, M.; van Kerrebroeck, P.; Kelleher, C. (2008)Drug therapy for overactive bladder (OAB) is associated with improvements in symptoms and quality of life, but the short- and long-term adherence and persistence is suboptimal. In this review we outline methods of measuring, ...